Abstract
The present project aims at the discovery of proteasome inhibitors. The proteasome is the main non-lysosomal proteolytic complex, and is already a validated target for the treatment of multiple myeloma, with potential validation for other human diseases, such as in the treatment of Chagas disease, leishmaniasis and inflammatory diseases. Thus, finding substances capable of inhibiting the …